Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Metzger

Showing results (391-400 of 415) with videos related to

Pageof 42
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 13, 2006
Cyclopentane-based human NK1 antagonists. Part 2: development of potent, orally active, water-soluble derivativesLaura C Meurer, Paul E Finke, Karen A Owens, et al.
Journal of Environmental Monitoring : JEM|January 24, 2007
An instrumented station for the survey of ozone and climate change in the southern tropicsJ L Baray, J Leveau, S Baldy, et al.
Diabetes|January 3, 2012
FGF21 analogs of sustained action enabled by orthogonal biosynthesis demonstrate enhanced antidiabetic pharmacology in rodentsJames Mu, Jason Pinkstaff, Zhihua Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2016
The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter's Syndrome Type II PhenotypeCaryn Hampton, Xiaoyan Zhou, Birgit T Priest, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of ObesityIyassu K Sebhat, Christopher Franklin, Michael M-C Lo, et al.
Cell Transplantation|November 2, 2024
Human Stem Cell-Derived Cardiomyocytes Integrate Into the Heart of Monkeys With Right Ventricular Pressure OverloadJodi Scholz, Frank J Secreto, Joan Wobig, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
Synthesis and SAR of heterocyclic carboxylic acid isosteres based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesityMark Hadden, Allan Goodman, Cheng Guo, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2010
Antiobesity effect of MK-5046, a novel bombesin receptor subtype-3 agonistXiao-Ming Guan, Joseph M Metzger, Liming Yang, et al.
Nature Genetics|September 6, 2000
Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body massA S Chen, D J Marsh, M E Trumbauer, et al.
Circulation|May 6, 2015
Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular DystrophyElizabeth M McNally, Jonathan R Kaltman, D Woodrow Benson, et al.
Pageof 42

Showing results (391-400 of 415) with videos related to

Sort By:
Pageof 42
Bioorganic & Medicinal Chemistry Letters|July 13, 2006
Cyclopentane-based human NK1 antagonists. Part 2: development of potent, orally active, water-soluble derivativesLaura C Meurer, Paul E Finke, Karen A Owens, et al.
Journal of Environmental Monitoring : JEM|January 24, 2007
An instrumented station for the survey of ozone and climate change in the southern tropicsJ L Baray, J Leveau, S Baldy, et al.
Diabetes|January 3, 2012
FGF21 analogs of sustained action enabled by orthogonal biosynthesis demonstrate enhanced antidiabetic pharmacology in rodentsJames Mu, Jason Pinkstaff, Zhihua Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2016
The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter's Syndrome Type II PhenotypeCaryn Hampton, Xiaoyan Zhou, Birgit T Priest, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of ObesityIyassu K Sebhat, Christopher Franklin, Michael M-C Lo, et al.
Cell Transplantation|November 2, 2024
Human Stem Cell-Derived Cardiomyocytes Integrate Into the Heart of Monkeys With Right Ventricular Pressure OverloadJodi Scholz, Frank J Secreto, Joan Wobig, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
Synthesis and SAR of heterocyclic carboxylic acid isosteres based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesityMark Hadden, Allan Goodman, Cheng Guo, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2010
Antiobesity effect of MK-5046, a novel bombesin receptor subtype-3 agonistXiao-Ming Guan, Joseph M Metzger, Liming Yang, et al.
Nature Genetics|September 6, 2000
Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body massA S Chen, D J Marsh, M E Trumbauer, et al.
Circulation|May 6, 2015
Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular DystrophyElizabeth M McNally, Jonathan R Kaltman, D Woodrow Benson, et al.
Pageof 42